In terms of therapeutics, MRPS12 has been associated with tamoxifen resistance in breast cancer [24], where combination therapies including tigecycline inhibited proliferation and enabled selective toxicity in cancer cells [33, 34]. Here, MRPS12 is linked to cancer.